Responses
Regular Abstracts – Part 2
Clinical Trial Completed
629-D The anti-tumor activity of IFNβ and membrane-stable CD40L expressing oncolytic virus MEM-288 in NSCLC patients is associated with modulation of the tumor microenvironment and systemic immune response
Compose a Response to This Article
Other responses
No responses have been published for this article.
